The Limited Times

Now you can see non-English news...

Russian company manufactures corona vaccine in Bavaria - but not for Germans?

2020-09-05T19:09:18.312Z


A Russian company wants to manufacture a vaccine against the coronavirus in Bavaria. Germany should not be supplied with it.


A Russian company wants to manufacture a vaccine against the coronavirus in Bavaria.

Germany should not be supplied with it.

  • The number of Corona * cases is increasing worldwide.

  • A Russian company wants to manufacture a vaccine in Bavaria.

  • Germany should not be supplied with the vaccine.

  • Here you will find the basic facts about the coronavirus * and the corona news from Bavaria.

    We also offer you the current case numbers in Bavaria on a map.

Illertissen - Russia sees itself at the forefront of international research with its corona vaccine *.

However, Russian companies

have also

entered into

collaborations

with other pharmaceutical groups, and a plant in Bavaria is now benefiting from this.

The news channel

ntv

reports

.

Coronavirus vaccine: Russian company invests in Illertissen location in Bavaria

The Russian pharmaceutical company

R-Pharm is

investing millions in the expansion of the

Illertissen

site in Bavaria

.

More than 20 million euros are to be invested in the plant there, as site manager Ivan Semenov

told

Südwest Presse

.

Production of a so-called

Oxford vaccine

against the

coronavirus is

scheduled to start there in the first quarter of 2021

.

The Russian

parent

company is investing in a sterile production facility in Illertissen, as

ntv

continues to report.

The capacity is designed for 500 million

vaccine doses

a year.

35 countries are to be supplied with the vaccine, including the CIS countries (Commonwealth of Independent States).

These include, for example, Russia, Kazakhstan and Armenia.

Germany

or other EU countries should not be supplied.

The Oxford vaccine (AZD1222) is currently in

testing

phase

III

,

i.e.

the crucial phase.

Company from #Russia manufactures #Corona vaccine in Bavaria https://t.co/KMBIjhWbWG

- Axel Huckstorf (@axelhuckstorf) September 5, 2020

AstraZeneca's corona vaccine candidate: three billion vaccine doses per year?

The vaccine candidate from pharmaceutical company AstraZeneca has

reached late stage clinical development

in the

United States

.

For the third phase of the

study

, only up to 30,000 participants are being sought to test the vaccine, as the company recently announced.

In July, the company announced that an early to mid-stage study had shown that the vaccine was "well tolerated and produced robust immune responses *" against the

virus

. Further

tests are

to be carried out in Brazil, South Africa and Russia, according to the

Independent

The pharmaceutical company has already signed

production

agreements with various countries, including Russia.

An annual production of three billion

vaccine doses is

targeted.

A few weeks ago, the EU had also signed a supply agreement with

AstraZeneca

for 400 cans, as

ntv

further reported.

The plant in Illertissen may also manufacture the “Sputnik V” vaccine at a later date.

It is already approved in Russia - despite concerns.

A vacationer from Germany disregarded a corona rule on a trip to Norway - it was expensive for him.

In the video: Scientists warn of the Russian corona vaccine

You can always read all the news from Bavaria with us.

(came) * Merkur.de is part of the nationwide Ippen-Digital editors network.

Source: merkur

All news articles on 2020-09-05

You may like

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.